"Ibritumomab" Pronounce,Meaning And Examples

"Ibritumomab" Meaning

Ibritumomab is a type of monoclonal antibody used in the treatment of non-Hodgkin's lymphoma, a type of cancer that affects the immune system. Specifically, it is used to treat relapsed or refractory B-cell non-Hodgkin's lymphoma.

"Ibritumomab" Examples

Usage Examples of Ibritumomab

1. Medical Context

Ibritumomab is a monoclonal antibody used in the treatment of non-Hodgkin's lymphoma. The patient received a combination of chemotherapy and ibritumomab to reduce the tumor size.

2. Research Article

In a recent clinical trial, researchers evaluated the efficacy of ibritumomab in combination with rituximab in patients with refractory non-Hodgkin's lymphoma. The results showed significant improvement in overall response rate.

3. Pharmaceutical Journal

Ibritumomab-tiuxetan is a biologic therapy indicated for the treatment of relapsed or refractory non-Hodgkin's lymphoma. The product label warns of potential severe infusion reactions.

4. Academic Paper

B-cell non-Hodgkin's lymphoma is often treated with ibritumomab, which targets the CD20 antigen on the surface of B cells. This targeted therapy has shown promise in improving patient outcomes.

5. Online Medical Encyclopedia

Ibritumomab is a type of biological response modifier used in the treatment of non-Hodgkin's lymphoma. It works by targeting and killing cancer cells that express the CD20 antigen on their surface.